Damian Wild

7.0k total citations
127 papers, 4.6k citations indexed

About

Damian Wild is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Damian Wild has authored 127 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Epidemiology, 57 papers in Oncology and 51 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Damian Wild's work include Neuroendocrine Tumor Research Advances (78 papers), Neuroblastoma Research and Treatments (40 papers) and Lung Cancer Research Studies (39 papers). Damian Wild is often cited by papers focused on Neuroendocrine Tumor Research Advances (78 papers), Neuroblastoma Research and Treatments (40 papers) and Lung Cancer Research Studies (39 papers). Damian Wild collaborates with scholars based in Switzerland, Germany and United Kingdom. Damian Wild's co-authors include Jean Claude Reubi, Melpomeni Fani, Guillaume Nicolas, Emanuel Christ, Helmut R. Maëcke, Helmut R. Mäcke, Beatrice Waser, Mihaela Ginj, Jean Rivier and Martin Béhé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Damian Wild

120 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Damian Wild Switzerland	36	2.9k	2.6k	1.7k	1.5k	607	127	4.6k
Roelf Valkema Netherlands	43	3.8k 1.3×	3.5k 1.4×	3.2k 1.9×	2.5k 1.7×	722 1.2×	168	7.2k
Jan Mueller‐Brand Switzerland	30	2.1k 0.7×	1.7k 0.7×	1.3k 0.8×	1.4k 1.0×	440 0.7×	48	3.5k
Wout A. P. Breeman Netherlands	40	4.1k 1.4×	3.3k 1.3×	2.6k 1.6×	2.3k 1.6×	363 0.6×	84	6.2k
Stanislas Pauwels Belgium	29	2.1k 0.7×	1.8k 0.7×	1.3k 0.8×	1.2k 0.8×	423 0.7×	76	3.5k
P.P.M. Kooij Netherlands	30	5.7k 1.9×	4.5k 1.8×	2.5k 1.5×	3.7k 2.5×	415 0.7×	39	7.2k
Alexander Haug Austria	42	1.6k 0.5×	1.8k 0.7×	2.0k 1.2×	1.0k 0.7×	774 1.3×	187	4.9k
Bo Wängberg Sweden	39	2.2k 0.8×	1.6k 0.6×	425 0.3×	1.5k 1.0×	1.1k 1.8×	124	3.9k
Marion de Jong Netherlands	33	1.7k 0.6×	1.7k 0.7×	1.7k 1.0×	780 0.5×	182 0.3×	75	3.6k
Michael R. Chicoine United States	43	1.5k 0.5×	515 0.2×	510 0.3×	1.9k 1.3×	767 1.3×	159	4.9k
Flavio Forrer Switzerland	27	1.3k 0.4×	1.2k 0.5×	1.4k 0.8×	634 0.4×	349 0.6×	51	2.9k

Countries citing papers authored by Damian Wild

Since Specialization

Citations

This map shows the geographic impact of Damian Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damian Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damian Wild more than expected).

Fields of papers citing papers by Damian Wild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damian Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damian Wild. The network helps show where Damian Wild may publish in the future.

Co-authorship network of co-authors of Damian Wild

This figure shows the co-authorship network connecting the top 25 collaborators of Damian Wild. A scholar is included among the top collaborators of Damian Wild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damian Wild. Damian Wild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wild, Damian, Philip Haaf, Felix Mahfoud, et al.. (2025). Prognostic value of myocardial perfusion imaging in asymptomatic high-risk diabetic patients: 10-year follow-up of the prospective multicentre BARDOT trial. European Heart Journal - Cardiovascular Imaging. 26(7). 1130–1139.

Schneider, I, Federico Caobelli, Damian Wild, et al.. (2025). Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (⁸²Rb-PET). Open Heart. 12(1). e003086–e003086.

Nicolas, Guillaume, Lisa McDougall, Felix Kaul, et al.. (2025). First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study. European Journal of Nuclear Medicine and Molecular Imaging. 53(2). 710–712.

McDougall, Lisa, Andreas Bauman, Peter Bernhardt, et al.. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study. Journal of Nuclear Medicine. 65(4). 573–579. 8 indexed citations

Erdil, Ertunç, Anton S. Becker, Moritz Schwyzer, et al.. (2024). Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks. Nature Communications. 15(1). 8402–8402. 1 indexed citations

Freitag, Martin T., Martin Braun, Guillaume Nicolas, et al.. (2023). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine. 65(2). 228–235. 12 indexed citations

Davies, John R., Thomas Menter, Damian Wild, et al.. (2023). Primary bone diffuse large B‐cell lymphoma (PB‐DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB‐like mutational profile and good prognosis. Histopathology. 84(3). 525–538. 4 indexed citations

Maushart, Claudia Irene, Wenfei Sun, Alaa Othman, et al.. (2023). Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men. EBioMedicine. 96. 104771–104771. 7 indexed citations

Refardt, Julie, Johannes Hofland, Damian Wild, & Emanuel Christ. (2022). Molecular Imaging of Neuroendocrine Neoplasms. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2662–e2670. 15 indexed citations

10.

Hicks, Rodney J., Clarisse Dromain, Wouter W. de Herder, et al.. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology. 34(3). e13040–e13040. 13 indexed citations

11.

Cattaneo, Marco, Lawrence Dierickx, Péter Igaz, et al.. (2021). Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers. 13(24). 6290–6290. 7 indexed citations

12.

Wild, Damian, Kwadwo Antwi, Melpomeni Fani, & Emanuel Christ. (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?. Journal of Nuclear Medicine. 62(Supplement 2). 44S–50S. 15 indexed citations

13.

Christ, Emanuel, Kwadwo Antwi, Melpomeni Fani, & Damian Wild. (2020). Innovative imaging of insulinoma: the end of sampling? A review. Endocrine Related Cancer. 27(4). R79–R92. 47 indexed citations

14.

Buechel, Ronny R., Beat A. Kaufmann, Daniel Tobler, Damian Wild, & Michael J. Zellweger. (2015). Non-invasive nuclear myocardial perfusion imaging improves the diagnostic yield of invasive coronary angiography. European Heart Journal - Cardiovascular Imaging. 16(8). 842–847. 11 indexed citations

15.

Wicki, Andreas, Damian Wild, Rosalba Mansi, et al.. (2014). Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors. EJNMMI Research. 4(1). 9–9. 4 indexed citations

16.

Zellweger, Michael J., Gregor Fahrni, Raban Jeger, et al.. (2014). Prognostic Value of “Routine” Cardiac Stress Imaging 5 Years After Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 7(6). 615–621. 18 indexed citations

17.

Christ, Emanuel, Damian Wild, Martin Béhé, et al.. (2013). Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. The Lancet Diabetes & Endocrinology. 1(2). 115–122. 135 indexed citations

18.

Win, Thida, Joanna C. Porter, Raymond Endozo, et al.. (2012). Novel Positron Emission Tomography/Computed Tomography of Diffuse Parenchymal Lung Disease Combining a Labeled Somatostatin Receptor Analogue and 2-Deoxy-2[F-18]Fluoro-D-Glucose. Bern Open Repository and Information System (University of Bern).

19.

Christ, Emanuel, Flavio Forrer, Damian Wild, et al.. (2012). Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations

20.

Wild, Damian, Hanwen Zhang, Aliyah Morgenstern, et al.. (2011). Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN). Cancer Research. 71(3). 1009–1018. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact